Bob Huff

Bob Huff's AIDS activist career began with ACT-UP (the AIDS Coalition to Unleash Power) in 1987. As a member of the group's Treatment and Data Committee, he participated in a series of major campaigns to force government agencies to develop more effective responses to the US AIDS epidemic. He also helped initiate the Statistical Working Group of the US-based AIDS Clinical Trials Group. This group brought scientists and activists into a then unprecedented collaboration to develop clinical trial protocols that maintained scientific rigor while responding more directly to the needs of people with HIV.

In the 1990s, Bob edited a quarterly treatment review published by the American Foundation for AIDS Research, studied biology at Columbia University, and earned a Master of Fine Arts degree at Bard College. He worked for Gay Men's Health Crisis (GMHC) from 2001 to 2006, speaking and writing on treatment policy issues with a focus on developing-world access, and was the editor of GMHC's Treatment Issues.

Since joining TAG in 2006, Bob has served as an expert community advisor to major HIV drug manufacturers and has participated in drug-pricing negotiations as a member of the Fair Pricing Coalition. He frequently provides commentary on drug development and access issues for researchers and the media. His assessments of optimal drug characteristics and critiques of drug development have been influential within the pharmaceutical industry and the US Food and Drug Administration.